Christiane Dolecek Selected Research

Infections

1/2018	Measuring and mapping the global burden of antimicrobial resistance.
1/2016	A Randomized Comparison of Chloroquine Versus Dihydroartemisinin-Piperaquine for the Treatment of Plasmodium vivax Infection in Vietnam.
5/2015	Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A.
4/2015	Undifferentiated febrile illness in Kathmandu, Nepal.
12/2010	Suitable disk antimicrobial susceptibility breakpoints defining Salmonella enterica serovar Typhi isolates with reduced susceptibility to fluoroquinolones.
8/2010	A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christiane Dolecek Research Topics

Disease

22	Typhoid Fever (Typhoid) 01/2022 - 06/2007
6	Infections 01/2018 - 08/2010
6	Fever (Fevers) 06/2017 - 06/2007
2	Malaria 01/2017 - 02/2007
2	Falciparum Malaria (Plasmodium falciparum Malaria) 10/2012 - 01/2004
1	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021
1	Salmonella Infections (Salmonellosis) 01/2020
1	Parasitemia 01/2016
1	Endemic Flea-Borne Typhus (Typhus, Endemic Flea Borne) 04/2015
1	Bacillary Dysentery (Shigellosis) 08/2011
1	Paratyphoid Fever 08/2010

Drug/Important Bio-Agent (IBA)

11	FluoroquinolonesIBA 01/2022 - 08/2010
8	Gatifloxacin (Zymar)FDA Link 06/2017 - 06/2007
4	Azithromycin (Zithromax)FDA LinkGeneric 01/2021 - 05/2008
4	Pharmaceutical PreparationsIBA 01/2020 - 05/2008
3	VaccinesIBA 01/2022 - 05/2016
3	artenimol (dihydroartemisinin)IBA 01/2016 - 01/2004
3	piperaquineIBA 01/2016 - 01/2004
3	Ofloxacin (Ofloxacine)FDA LinkGeneric 04/2015 - 12/2010
3	Nalidixic Acid FDA Link 01/2013 - 05/2008
2	Conjugate VaccinesIBA 01/2022 - 01/2020
2	Cefixime (Suprax)FDA Link 01/2021 - 06/2007
2	Cephalosporins (Cephalosporin Antibiotics)IBA 11/2017 - 05/2016
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2017 - 05/2016
2	artemisinin (artemisinine)IBA 01/2017 - 10/2012
2	ArtesunateIBA 10/2012 - 01/2004
2	Ciprofloxacin (Cipro)FDA LinkGeneric 08/2011 - 12/2010
2	Antimalarials (Antimalarial Agents)IBA 02/2007 - 01/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	TCVSIBA 01/2020
1	MacrolidesIBA 11/2017
1	Third Generation CephalosporinsIBA 05/2016
1	Chloroquine (Aralen)FDA LinkGeneric 01/2016
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2014
1	HLA-DRB1*04 antigenIBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 06/2014
1	Chloramphenicol (Chloromycetin)FDA Link 06/2011
1	Drinking WaterIBA 11/2010
1	Biological ProductsIBA 05/2010
1	DNA (Deoxyribonucleic Acid)IBA 05/2010
1	Mefloquine (Lariam)FDA LinkGeneric 01/2004
1	Trimethoprim (Proloprim)FDA LinkGeneric 01/2004

Therapy/Procedure

2	Therapeutics 11/2017 - 01/2017
1	Length of Stay 01/2018
1	Aftercare (After-Treatment) 05/2016
1	Duration of Therapy 06/2011